Padsevonil is under investigation in clinical trial NCT03695094 (A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil). The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include padsevonilum, (4R)-4-(2-chloro-2, 2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2, 1-b][1, 3 and 4]thiadiazol-5-yl]methyl]pyrrolidin-2-one. Its PubChem CID is 52911611.
Padsevonil
| CAS No | 1294000-61-5 |
|---|---|
| Molecular Formula | C14H14ClF5N4O2S |
| Molecular Weight | 432.8 g/mol |
| Synonyms | (4R)-4-(2-chloro-2,2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl]pyrrolidin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Padsevonil is under investigation in clinical trial NCT03695094 (A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil).
The listed CAS number is 1294000-61-5.
The listed molecular formula is C14H14ClF5N4O2S.
The listed molecular weight is 432.8 g/mol.
(4R)-4-(2-chloro-2,2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl]pyrrolidin-2-one.
The source lists padsevonilum, (4R)-4-(2-chloro-2, 2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2, 1-b][1, 3 and 4]thiadiazol-5-yl]methyl]pyrrolidin-2-one.